[1]
“Survival determinants and treatment patterns in a European multi-center cohort of patients with nasopharyngeal carcinoma”, Med Pharm Rep, vol. 99, no. 4, pp. 335–344, Jul. 2026, doi: 10.15386/mpr-2999.